AJO LP’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,557
Closed -$3.04M 727
2020
Q2
$3.04M Buy
+11,557
New +$3.08M 0.03% 326
2020
Q1
Sell
-55,297
Closed -$16.7M 676
2019
Q4
$16.7M Sell
55,297
-7,294
-12% -$2.01M 0.1% 171
2019
Q3
$15M Sell
62,591
-98,042
-61% -$26.9M 0.09% 180
2019
Q2
$45.3M Buy
160,633
+17,936
+13% +$4.9M 0.24% 125
2019
Q1
$41M Buy
142,697
+102,221
+253% +$29.6M 0.21% 127
2018
Q4
$10.6M Buy
40,476
+2,381
+6% +$655K 0.06% 219
2018
Q3
$10.4M Sell
38,095
-22,748
-37% -$5.91M 0.05% 236
2018
Q2
$14.5M Sell
60,843
-322,198
-84% -$74.6M 0.07% 204
2018
Q1
$84.2M Sell
383,041
-19,657
-5% -$4.62M 0.39% 85
2017
Q4
$90.6M Buy
402,698
+353,133
+712% +$75.2M 0.39% 85
2017
Q3
$9.41M Buy
49,565
+6,557
+15% +$1.25M 0.04% 239
2017
Q2
$8.09M Sell
43,008
-7,982
-16% -$1.43M 0.03% 244
2017
Q1
$8.43M Buy
50,990
+2,600
+5% +$414K 0.03% 226
2016
Q4
$6.96M Sell
48,390
-30,898
-39% -$4.14M 0.03% 247
2016
Q3
$9.94M Sell
79,288
-5,991
-7% -$774K 0.04% 222
2016
Q2
$11.2M Sell
85,279
-130,725
-61% -$17.9M 0.05% 216
2016
Q1
$30M Sell
216,004
-39,815
-16% -$5.32M 0.13% 148
2015
Q4
$35.7M Sell
255,819
-585,004
-70% -$80.6M 0.15% 124
2015
Q3
$118M Sell
840,823
-78,337
-9% -$11.8M 0.54% 65
2015
Q2
$151M Sell
919,160
-682,010
-43% -$109M 0.64% 53
2015
Q1
$247M Sell
1,601,170
-113,210
-7% -$16.1M 1.03% 27
2014
Q4
$215M Buy
1,714,380
+25,370
+2% +$3.13M 0.91% 40
2014
Q3
$202M Sell
1,689,010
-105,380
-6% -$12.1M 0.9% 47
2014
Q2
$193M Sell
1,794,390
-44,180
-2% -$4.55M 0.83% 49
2014
Q1
$183M Sell
1,838,570
-964,864
-34% -$87.3M 0.8% 65
2013
Q4
$259M Sell
2,803,434
-374,366
-12% -$33.3M 1.13% 22
2013
Q3
$266M Buy
3,177,800
+2,500,400
+369% +$214M 1.21% 14
2013
Q2
$55.4M Buy
+677,400
New +$50.7M 0.26% 101

Other funds holding ELV

AJO LP's ELV Position: Q3 2020 in Review

AJO LP sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 11,557 shares — an estimated $3.04M sold.

AJO LP first reported a position in ELV in Q2 2013 and held it in 28 quarters. The position peaked at $266M in Q3 2013. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • AJO LP reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • AJO LP sold 11,557 Elevance Health shares in Q3 2020, an estimated $3.04M.
  • AJO LP first reported a position in Elevance Health in Q2 2013 and held it in 28 quarters.
  • AJO LP's Elevance Health position peaked at $266M in Q3 2013.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on AJO LP's 13F filing for Q3 2020, filed 10 Nov 2020.